UK Markets open in 5 hrs 11 mins

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
177.33+0.09 (+0.05%)
At close: 04:00PM EST
177.96 +0.63 (+0.36%)
After hours: 07:58PM EST
Full screen
Trade prices are not sourced from all markets
Previous close177.24
Open176.75
Bid0.00 x 1000
Ask0.00 x 900
Day's range176.56 - 177.77
52-week range155.72 - 186.69
Volume5,934,752
Avg. volume7,026,070
Market cap466.839B
Beta (5Y monthly)0.56
PE ratio (TTM)31.32
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield4.52 (2.62%)
Ex-dividend date21 Nov 2022
1y target estN/A
  • Business Wire

    Johnson & Johnson to Acquire Abiomed

    NEW BRUNSWICK, N.J. & DANVERS, Mass., November 01, 2022--Johnson & Johnson (NYSE: JNJ), the world’s largest, most diversified healthcare products company, and Abiomed (NASDAQ: ABMD), a world leader in breakthrough heart, lung and kidney support technologies, today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.00 per share in cash, corresponding to an

  • Business Wire

    Johnson & Johnson Reports Q3 2022 Results

    NEW BRUNSWICK, N.J., October 18, 2022--Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2022. "Our third quarter performance demonstrates our continued strength and resilience across all three of our businesses," said Joaquin Duato, Chief Executive Officer. "Through the ongoing efforts of our teams around the world, we continue to navigate the dynamic macroeconomic environment and remain focused on delivering transformative healthcare solutions. Looking ahead, I remain con

  • Business Wire

    Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference

    NEW BRUNSWICK, N.J., October 03, 2022--Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 31st Annual Global Healthcare Conference on Thursday, November 10th, 2022 at the Terranea Resort in Rancho Palos Verdes, CA. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 12:50 p.m. (Eastern Time).